Literature DB >> 8612579

Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.

Y Yamanaka1, K Nakajima, T Fukada, M Hibi, T Hirano.   

Abstract

Interleukin-6 (IL-6) induces growth arrest and macrophage differentiation through its receptor in a murine myeloid leukaemic cell line, M1, although it is largely unknown how the IL-6 receptor generates these signals. By using chimeric receptors consisting of the extracellular domain of growth hormone receptor and the transmembrane and cytoplasmic domain of gp130 with progressive C-terminal truncations, we showed that the membrane-proximal 133, but not 108, amino acids of gp130 could generate the signals for growth arrest, macrophage differentiation, down-regulation of c-myc and c-myb, induction of junB and IRF1 and Stat3 activation. Mutational analysis of this region showed that the tyrosine residue with the YXXQ motif was critical not only for Stat3 activation but also for growth arrest and differentiation, accompanied by down-regulation of c-myc and c-myb and immediate early induction of junB and IRF1. The tight correlation between Stat3 activation and other IL-6 functions was further observed in the context of the full-length cytoplasmic region of gp130. The result suggest that Stat3 plays an essential role in the signals for growth arrest and differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612579      PMCID: PMC450065     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  Molecular cloning and expression of an IL-6 signal transducer, gp130.

Authors:  M Hibi; M Murakami; M Saito; T Hirano; T Taga; T Kishimoto
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

Review 2.  Interleukin-6: an overview.

Authors:  J Van Snick
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130.

Authors:  T Taga; M Hibi; Y Hirata; K Yamasaki; K Yasukawa; T Matsuda; T Hirano; T Kishimoto
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

4.  Versatile retroviral vectors for potential use in gene therapy.

Authors:  R G Hawley; F H Lieu; A Z Fong; T S Hawley
Journal:  Gene Ther       Date:  1994-03       Impact factor: 5.250

5.  Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2.

Authors:  L Chen; Y Mory; A Zilberstein; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6.

Authors:  Y Shabo; J Lotem; M Rubinstein; M Revel; S C Clark; S F Wolf; R Kamen; L Sachs
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

7.  Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1).

Authors:  C Miyaura; K Onozaki; Y Akiyama; T Taniyama; T Hirano; T Kishimoto; T Suda
Journal:  FEBS Lett       Date:  1988-07-04       Impact factor: 4.124

8.  Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation.

Authors:  K A Lord; A Abdollahi; S M Thomas; M DeMarco; J S Brugge; B Hoffman-Liebermann; D A Liebermann
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.

Authors:  B Hoffman-Liebermann; D A Liebermann
Journal:  Oncogene       Date:  1991-06       Impact factor: 9.867

10.  Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc.

Authors:  B Hoffman-Liebermann; D A Liebermann
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

View more
  50 in total

1.  Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.

Authors:  H Nishio; K Matsui; H Tsuji; A Tamura; K Suzuki
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

2.  Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.

Authors:  M C Rouyez; C Boucheron; S Gisselbrecht; I Dusanter-Fourt; F Porteu
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Dual control of neurite outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6.

Authors:  S Ihara; K Nakajima; T Fukada; M Hibi; S Nagata; T Hirano; Y Fukui
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

4.  IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro.

Authors:  Shoichi Kaneshiro; Kosuke Ebina; Kenrin Shi; Chikahisa Higuchi; Makoto Hirao; Michio Okamoto; Kota Koizumi; Tokimitsu Morimoto; Hideki Yoshikawa; Jun Hashimoto
Journal:  J Bone Miner Metab       Date:  2014-07       Impact factor: 2.626

5.  Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase.

Authors:  M Takahashi-Tezuka; Y Yoshida; T Fukada; T Ohtani; Y Yamanaka; K Nishida; K Nakajima; M Hibi; T Hirano
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

6.  STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition.

Authors:  T Fukada; T Ohtani; Y Yoshida; T Shirogane; K Nishida; K Nakajima; M Hibi; T Hirano
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

7.  Cytoplasmic domains of the common beta-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines.

Authors:  A Smith; D Metcalf; N A Nicola
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

8.  In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas.

Authors:  Omar Shkeir; Maria Athanassiou-Papaefthymiou; Martian Lapadatescu; Petros Papagerakis; Michael J Czerwinski; Carol R Bradford; Thomas E Carey; Mark E P Prince; Gregory T Wolf; Silvana Papagerakis
Journal:  Head Neck       Date:  2013-01-16       Impact factor: 3.147

9.  Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.

Authors:  F Schaper; C Gendo; M Eck; J Schmitz; C Grimm; D Anhuf; I M Kerr; P C Heinrich
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

10.  Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium.

Authors:  Rong Wu; Shishinn Sun; Bettie M Steinberg
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.